Global Small Molecule API Market Research Report: Information, by Types (Synthetic/Chemical API and Biological API), Application (Cardiovascular, Oncology, Diabetes, Immunological Disorders and others), Manufacturing Method (In-House and Contract) and Region (North America, Europe, Asia-Pacific and the Middle East & Africa) - Forecast To 2027
ID: MRFR/Pharma/0279-CR | August 2019 | Region: Global | 109 pages
The Global Small Molecule API Market is expected to register 7.0% CAGR and is projected to reach USD 279,687.1 Million by 2027. Small molecules are the organic compounds having low molecular weight, which is approximately less than 900 Daltons. It includes lipids, monosaccharides, secondary messengers, other natural products and metabolites, drugs, and other xenobiotics.
Any drug is composed of two components or aspects. The first is the actual API or Active Pharmaceutical Ingredients, which is the central ingredient. Active Pharmaceutical Ingredients are portions of any drug, which are chemically active, which are meant to produce the desired effect in the body.
Market Dynamics
Growing demand for newly developed small molecules drugs. The pharmaceutical small molecule API manufacturing industry is now experiencing a period of rapid change. This change is being driven by factors such as the changing nature of the drugs being made. Small-molecule drugs accounted for 84% of pharmaceutical industry revenues in 2014. In addition, small-molecule drugs still account for approximately two-thirds of the candidates in the current robust pharmaceutical industry. There has been a significant development in the small molecule API manufacturing in the segments such as oncology, cardiovascular, and metabolic disorders. The demand for the small molecule API drugs in such segments in unprecedented.
Global Small Molecule API Market Size, by Application, 2016 (USD Million) 
Source: MRFR Analysis
Segmentation
The global small molecule API market has been segmented into type, application, and manufacturing methods.
Based on type, the global market is divided into synthetic/chemical API and biological API. The synthetic/chemical API segment accounted for the largest market share of global small molecule API market. Chemical active pharmaceutical ingredients are the synthetic compounds, which need to be produced in a laboratory or manufacturing unit. The production of chemical active pharmaceutical ingredients involves a variety of process steps that must be optimally coordinated.
Based on application, the global market has been segmented into cardiovascular, oncology, diabetes, and immunological disorders. The cardiovascular segment held the maximum share in the small molecule API market in 2015. Small molecules API play an important role in medicinal preparations used for the treatment of heart failure and disorders of vascular tensions. Some examples of cardiovascular API drugs are Propranolol Hydrochloride and Nifedipine.
Based on manufacturing methods, the global market is segmented into in-house manufacturing (Captive) and contract manufacturing (CMO). The in-house manufacturing segment commands a maximum share of small molecules market with 6.6% CAGR. Currently, 80% of all the drugs are made of small molecules.
Key Players
The major players in the global small molecule API market are Albemarle Corporation (North Carolina), Allergan plc (Ireland), AUROBINDO PHARMA (India), Cambrex Corporation (US), Dr. Reddy’s Laboratories Ltd (India), GlaxoSmithKline plc (UK), Lonza (Switzerland), Merck Sharp & Dohme Corp. (US), Mylan N.V.(US), Novartis AG(Basel-Stadt), Pfizer Inc.(New York), Siegfried AG (Switzerland), Sun Pharmaceutical Industries Ltd (India), and Teva Pharmaceutical Industries Ltd (Israel).
Some of the key strategies followed by the players operating in the global small molecule API market are adopting various strategies to expand their small molecule API business and enhance their market share.
Global Small Molecule API Market Share, by Region, 2016 (%) 
Source: MRFR Analysis
Regional Analysis
The global small molecule API market, based on region, is segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa.
North America accounted for the largest share in the small molecule API market. The active pharmaceutical ingredients market in the region is being changed as large pharmaceutical organizations dedicate assets increasingly to the improvement of biologic solutions.
Europe accounted for the third-largest regional market owing to the initiatives that have been taken to supporting generic drug growth with pricing and reimbursement, as CMOs expected to account for the majority of the manufacturing activity providing accurate understanding in the market. Germany accounted for the largest market share in the European small molecule API market, registering USD 7,435.9 million in revenue in 2015. Asia-Pacific is expected to accomplish the most elevated development in the global small molecule API market during the forecast period on account of the populace demographics in this geography. According to BioPharm International, India as of now accounts for roughly 8% of the worldwide pharmaceutical generation. However, the Middle East & Africa is expected to observe slow growth due to less exposure to healthcare services and stringent government rules and regulations. The market for small molecule API in Africa is growing at a steady pace.
Key Updates
- In March 2015, Patheon acquired Irix (Florence, SC), a mid-size API manufacturer with development and commercial capabilities. The acquisition added small-molecule capabilities to Patheon’s offerings in large-molecule API and dosage forms.
- In July 2015, AMRI announced it would acquire Gadea Pharmaceutical Group (Valladolid, Spain), a specialist in hormone and steroid APIs.
- In August 2016, Allergan Plc announced the acquisition of Eye Care Company ForSight VISION5 Adding Peri-Ocular Ring Technology to its portfolio of innovative eye health products.
- In June 2016, Albemarle Corporation announced the definitive agreement to sell its Chemetall Surface Treatment business to BASF in a cash transaction valued at approximately USD 3.2 billion.
Market Segmentation
Global Small Molecule API Market, by Type
- Synthetic/Chemical API
- Biological API
Small Molecule API Market, by Application
- Cardiovascular
- Oncology
- Diabetes
- Immunological disorders
Global Small Molecule API Market, by Manufacturing Methods
- In-House Manufacturing
- Contract Manufacturing
Global Small Molecule API Market, by Region
- North America
- US
- Canada
- Europe
- Western Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Available Additional Customizations
- Additional Companies
- Gilead Sciences, Inc.
- Advanced Brain Monitoring
- Amneal Pharmaceuticals LLC.
- Breckenridge Pharmaceutical, Inc.
- Lupin Pharmaceuticals, Inc.
- Camber Pharmaceuticals, Inc.
Intended Audience
- Pharmaceutical companies
- Contract manufacturing organizations
- Research and academic institutes
- Government research organizations
- Hospitals and clinics
- Regulatory agencies
Frequently Asked Questions (FAQ) :
The CAGR would be 7% during the forecast period of 2020 to 2027.
small molecule API market valuation would be USD 279,687.1 million.
small molecule API market has segments like diabetes, oncology, cardiovascular, and immunological disorders.
The segments are in-house manufacturing (Captive) and contract manufacturing (CMO).
The types included are synthetic/chemical API and biological API.
1 INTRODUCTION
1.1 DEFINITION 12
1.2 SCOPE OF STUDY 12
1.2.1 RESEARCH OBJECTIVE 12
1.2.2 ASSUMPTIONS & LIMITATIONS 13
1.2.2.1 ASSUMPTIONS 13
1.2.2.2 LIMITATIONS 13
1.3 MARKET STRUCTURE: 13
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS: 14
2.2 PRIMARY RESEARCH 15
2.3 SECONDARY RESEARCH: 15
3 MARKET DYNAMICS
3.1 DRIVERS 16
3.1.1 GROWING DEMAND FOR NEWLY DEVELOPED SMALL MOLECULES DRUGS 16
3.1.2 GROWING TREND OF OUTSOURCING 16
3.1.3 GROWING PHARMACEUTICAL INDUSTRY IN DEVELOPING NATIONS 17
3.2 RESTRAINTS 17
3.2.1 AUSTERITY MEASURES IN EUROPE 17
3.3 OPPORTUNITIES 17
3.4 MACROECONOMIC INDICATORS 18
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL 19
4.2 BARGAINING POWER OF SUPPLIERS 20
4.3 BARGAINING POWER OF BUYERS 20
4.4 THREAT OF NEW ENTRANTS 20
4.5 THREAT OF SUBSTITUTES 20
4.6 INTENSITY OF RIVALRY 20
5 SMALL MOLECULES API, BY TYPE
5.1 SYNTHETIC/CHEMICAL API 22
5.2 BIOLOGICAL API 23
6 SMALL MOLECULE API MARKET, BY APPLICATION
6.1 CARDIOVASCULAR 27
6.2 ONCOLOGY 28
6.3 DIABETES 29
6.4 IMMUNOLOGICAL DISORDERS 30
7 SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS
7.1 IN-HOUSE MANUFACTURING 33
7.2 CONTRACT MANUFACTURING 34
7.2.1 INTRODUCTION 34
8 GLOBAL SMALL MOLECULE API MARKET, BY REGION
8.1 NORTH AMERICA 39
SMALL MOLECULES API, BY TYPE
SMALL MOLECULE API MARKET, BY APPLICATION
SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS
8.1.1 INTRODUCTION 40
8.2 EUROPE 46
SMALL MOLECULES API, BY TYPE
SMALL MOLECULE API MARKET, BY APPLICATION
SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS
8.2.1 INTRODUCTION 47
8.3 ASIA-PACIFIC 58
SMALL MOLECULES API, BY TYPE
SMALL MOLECULE API MARKET, BY APPLICATION
SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS
8.3.1 INTRODUCTION 59
8.4 MIDDLE EAST & AFRICA 72
SMALL MOLECULES API, BY TYPE
SMALL MOLECULE API MARKET, BY APPLICATION
SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS
8.4.1 INTRODUCTION 76
9 COMPETITIVE LANDSCAPE
9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS 77
9.1.1 STRATEGIC PARTNERSHIP 78
9.1.2 MERGER & ACQUISITION 78
10 COMPANY PROFILE
10.1 ALBEMARLE CORPORATION 80
10.1.1 OVERVIEW 80
10.1.2 PRODUCT OVERVIEW 80
10.1.3 FINANCIALS 81
10.1.4 KEY DEVELOPMENTSS 81
10.2 ALLERGAN PLC 82
10.2.1 OVERVIEW 82
10.2.2 PRODUCT OVERVIEW 82
10.2.3 FINANCIALS 83
10.2.4 KEY DEVELOPMENTSS 83
10.3 AUROBINDO PHARMA 84
10.3.1 OVERVIEW 84
10.3.2 PRODUCT OVERVIEW 84
10.3.3 FINANCIALS 85
10.3.4 STRATEGIES 85
10.3.5 KEY DEVELOPMENTS 85
10.4 CAMBREX CORPORATION 86
10.4.1 OVERVIEW 86
10.4.2 PRODUCT OVERVIEW 86
10.4.3 FINANCIALS 87
10.4.4 KEY DEVELOPMENTS 87
10.5 DR. REDDY’S LABORATORIES LTD. 88
10.5.1 OVERVIEW 88
10.5.2 PRODUCT OVERVIEW 88
10.5.3 FINANCIALS 89
10.5.4 KEY DEVELOPMENTS 89
10.6 GLAXOSMITHKLINE PLC 90
10.6.1 OVERVIEW 90
10.6.2 PRODUCT OVERVIEW 90
10.6.3 FINANCIALS 91
10.6.4 STRATEGIES 91
10.6.5 KEY DEVELOPMENTS 92
10.7 LONZA 92
10.7.1 OVERVIEW 92
10.7.2 PRODUCT OVERVIEW 92
10.7.3 FINANCIALS 93
10.7.4 STRATEGIES 93
10.7.5 KEY DEVELOPMENTS 94
10.8 MERCK SHARP & DOHME CORP. 94
10.8.1 OVERVIEW 94
10.8.2 PRODUCT OVERVIEW 95
10.8.3 FINANCIAL 95
10.8.4 KEY DEVELOPMENTS 96
10.9 MYLAN N.V. 96
10.9.1 OVERVIEW 96
10.9.2 PRODUCT OVERVIEW 97
10.9.3 FINANCIALS 97
10.9.4 KEY DEVELOPMENTS 98
10.10 NOVARTIS AG 98
10.10.1 OVERVIEW 98
10.10.2 PRODUCT OVERVIEW 99
10.10.3 FINANCIALS 99
10.10.4 STRATEGIES 99
10.10.5 DEVELOPMENTS 100
10.11 PFIZER INC. 100
10.11.1 OVERVIEW 100
10.11.2 PRODUCT OVERVIEW 101
10.11.3 FINANCIALS 101
10.11.4 KEY DEVELOPMENTS 102
10.12 SIEGFRIED AG 102
10.12.1 OVERVIEW 102
10.12.2 PRODUCT OVERVIEW 102
10.12.3 FINANCIALS 103
10.12.4 KEY DEVELOPMENTS 103
10.13 SUN PHARMACEUTICAL INDUSTRIES LTD. 104
10.13.1 OVERVIEW 104
10.13.2 PRODUCT OVERVIEW 104
10.13.3 FINANCIALS 105
10.13.4 KEY DEVELOPMENTS 105
10.14 TEVA PHARMACEUTICAL INDUSTRIES LTD 106
10.14.1 OVERVIEW 106
10.14.2 PRODUCT OVERVIEW 106
10.14.3 FINANCIALS 107
10.14.4 STRATEGIES 107
10.14.5 KEY DEVELOPMENTS 108
11 LIST OF TABLES
TABLE 1 GLOBAL SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 22
TABLE 2 GLOBAL SYNTHETIC/CHEMICAL API MARKET, BY REGION, 2020–2027 (USD MILLION) 23
TABLE 3 GLOBAL BIOLOGICAL API MARKET, BY REGION, 2020–2027 (USD MILLION) 24
TABLE 4 GLOBAL SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 26
TABLE 5 GLOBAL SMALL MOLECULE API MARKET: CARDIOVASCULAR, BY REGION, 2020–2027 (USD MILLION) 27
TABLE 6 GLOBAL SMALL MOLECULE API MARKET: ONCOLOGY, BY REGION, 2020–2027 (USD MILLION) 28
TABLE 7 GLOBAL SMALL MOLECULE API MARKET: DIABETES, BY REGION, 2020–2027 (USD MILLION) 29
TABLE 8 GLOBAL SMALL MOLECULE API MARKET: IMMUNOLOGICAL DISORDERS, BY REGION, 2020–2027 (USD MILLION) 30
TABLE 9 GLOBAL SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 32
TABLE 10 GLOBAL SMALL MOLECULE API MARKET, BY IN-HOUSE MANUFACTURING, 2020–2027 (USD MILLION) 33
TABLE 11 GLOBAL SMALL MOLECULE API MARKET, BY CONTRACT MANUFACTURING, 2020–2027 (USD MILLION) 34
TABLE 12 GLOBAL SMALL MOLECULE API MARKET, BY REGION, 2020–2027 (USD MILLION) 38
TABLE 13 NORTH AMERICA SMALL MOLECULE API MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 39
TABLE 14 NORTH AMERICA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 40
TABLE 15 NORTH AMERICA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 41
TABLE 16 NORTH AMERICA SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 42
TABLE 17 US SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 43
TABLE 18 US SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 44
TABLE 19 US SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 44
TABLE 20 CANADA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 45
TABLE 21 CANADA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 45
TABLE 22 CANADA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 46
TABLE 23 EUROPE SMALL MOLECULE API MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 47
TABLE 24 EUROPE SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 48
TABLE 25 EUROPE SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 49
TABLE 26 EUROPE SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 50
TABLE 27 GERMANY SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 51
TABLE 28 GERMANY SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 51
TABLE 29 GERMANY SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 52
TABLE 30 FRANCE SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 52
TABLE 31 FRANCE SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 53
TABLE 32 FRANCE SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 53
TABLE 33 UK SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 54
TABLE 34 UK SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 54
TABLE 35 UK SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 55
TABLE 36 ITALY SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 55
TABLE 37 ITALY SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 56
TABLE 38 ITALY SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 56
TABLE 39 SPAIN SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 57
TABLE 40 SPAIN SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 57
TABLE 41 SPAIN SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 58
TABLE 42 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 59
TABLE 43 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 60
TABLE 44 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 61
TABLE 45 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 62
TABLE 46 JAPAN SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 63
TABLE 47 JAPAN SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 63
TABLE 48 JAPAN SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 64
TABLE 49 CHINA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 64
TABLE 50 CHINA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 65
TABLE 51 CHINA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 65
TABLE 52 INDIA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 66
TABLE 53 INDIA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 66
TABLE 54 INDIA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 67
TABLE 55 SOUTH KOREA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 68
TABLE 56 SOUTH KOREA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 68
TABLE 57 SOUTH KOREA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 69
TABLE 58 AUSTRALIA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 70
TABLE 59 AUSTRALIA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 70
TABLE 60 AUSTRALIA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 71
TABLE 61 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY REGION, 2020–2027 (USD MILLION) 72
TABLE 62 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 73
TABLE 63 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 74
TABLE 64 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 75
12 LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS 14
FIGURE 2 PORTERS FIVE FORCES MODEL 19
FIGURE 3 GLOBAL SMALL MOLECULE API MARKET, BY TYPE 22
FIGURE 4 GLOBAL SMALL MOLECULE API MARKET, BY APPLICATION 26
FIGURE 5 GLOBAL SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 32
FIGURE 6 CONTRACT MANUFACTURING ORGANIZATIONS: MARKET SHARE ANALYSIS (%) 35
FIGURE 7 GLOBAL SMALL MOLECULE API MARKET, BY REGION 38
FIGURE 8 NORTH AMERICA SMALL MOLECULE API MARKET, BY COUNTRY (%) 39
FIGURE 9 NORTH AMERICA SMALL MOLECULE API MARKET, BY TYPE 40
FIGURE 10 NORTH AMERICA SMALL MOLECULE API MARKET, BY APPLICATION 41
FIGURE 11 NORTH AMERICA SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD 42
FIGURE 12 EUROPE SMALL MOLECULE API MARKET, BY COUNTRY (%) 46
FIGURE 13 EUROPE SMALL MOLECULE API MARKET, BY TYPE 48
FIGURE 14 EUROPE SMALL MOLECULE API MARKET, BY APPLICATION 49
FIGURE 15 EUROPE SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD 50
FIGURE 16 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY COUNTRY (%) 58
FIGURE 17 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY TYPE 60
FIGURE 18 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY APPLICATION 61
FIGURE 19 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 62
FIGURE 20 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY COUNTRY (%) 72
FIGURE 21 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY TYPE 73
FIGURE 22 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY APPLICATION 74
FIGURE 23 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 75
FIGURE 24 GLOBAL SMALL MOLECULE API MARKET: COMPANY SHARE ANALYSIS, 2020 (%) 77
